PPD Paid $77 Million to Acquire BioDuro

In reporting that it has closed its acquisition of BioDuro, PPD, Inc. announced it paid $77 million for BioDuro. The price was not previously released, nor has PPD disclosed the annual revenues of privately held BioDuro. PPD did say that, post-acquisition, it has nearly 1,000 employees in China. Of these, almost 660 came from BioDuro. The company now claims to be the largest CRO in China offering both clinical development and discovery services. More details... Stock Symbol: (NSDQ: PPDI)